| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 59,8 M € | -3.0% | 61,6 M € | -10.3% | 68,7 M € | -13.0% | 78,9 M € | +3.5% | 76,2 M € | +33.9% | 56,9 M € | -7.9% | 61,8 M € | -4.6% | 64,8 M € | -2.0% | 66,1 M € | +4.4% | 63,3 M € | -0.6% | 63,7 M € | +3.6% | 61,5 M € | +3.8% | 59,2 M € | -3.2% | 61,2 M € | -1.0% | 61,8 M € | +11.1% | 55,6 M € | +9.5% | 50,8 M € | |
| EBITDA | 6,6 M € | -17.8% | 8,0 M € | -16.1% | 9,6 M € | -14.2% | 11,1 M € | +15.7% | 9,6 M € | +40.6% | 6,8 M € | +73.6% | 3,9 M € | +3.8% | 3,8 M € | -70.0% | 12,7 M € | +127.3% | 5,6 M € | +7.1% | 5,2 M € | +6.5% | 4,9 M € | +250.5% | 1,4 M € | -31.5% | 2,0 M € | +38.8% | 1,5 M € | -42.5% | 2,5 M € | -54.8% | 5,6 M € | |
| Operating profit | 5,1 M € | -23.0% | 6,7 M € | -17.0% | 8,0 M € | -13.3% | 9,3 M € | +25.7% | 7,4 M € | +85.4% | 4,0 M € | +596.3% | 571,3 k € | -55.0% | 1,3 M € | -88.0% | 10,6 M € | +266.4% | 2,9 M € | -14.6% | 3,4 M € | +2.2% | 3,3 M € | +1916.9% | -182,8 k € | -130.1% | 608,1 k € | +216.0% | 192,4 k € | -73.1% | 716,5 k € | -76.6% | 3,1 M € | |
| Profit/loss | 29,3 M € | +90.0% | 15,4 M € | +800.4% | 1,7 M € | -48.3% | 3,3 M € | +21.6% | 2,7 M € | +27.6% | 2,1 M € | +220.0% | -1,8 M € | -459.2% | 494,9 k € | -95.1% | 10,2 M € | +1444.6% | 659,5 k € | -73.5% | 2,5 M € | -10.7% | 2,8 M € | +665.7% | -492,3 k € | +83.5% | -3,0 M € | -356.0% | 1,2 M € | +164.8% | -1,8 M € | -238.3% | 1,3 M € | |
| Equity | 54,8 M € | +114.8% | 25,5 M € | -9.2% | 28,1 M € | +6.5% | 26,4 M € | +14.3% | 23,1 M € | +13.4% | 20,3 M € | +17.9% | 17,3 M € | -9.3% | 19,0 M € | -39.9% | 31,7 M € | +47.4% | 21,5 M € | -14.0% | 25,0 M € | +10.3% | 22,6 M € | +14.0% | 19,9 M € | -3.8% | 20,6 M € | -12.6% | 23,6 M € | +5.2% | 22,5 M € | -7.4% | 24,3 M € | |
| Total assets | 180,2 M € | -8.3% | 196,5 M € | +15.7% | 169,9 M € | +26.7% | 134,1 M € | -2.9% | 138,2 M € | +25.2% | 110,3 M € | +29.4% | 85,3 M € | +109.0% | 40,8 M € | -23.7% | 53,5 M € | -2.6% | 54,9 M € | +36.5% | 40,2 M € | +7.2% | 37,5 M € | -5.1% | 39,6 M € | -9.5% | 43,7 M € | +6.0% | 41,3 M € | +4.9% | 39,3 M € | +3.5% | 38,0 M € | |
| Cash | 8,6 M € | +46.0% | 5,9 M € | -21.7% | 7,5 M € | +180.7% | 2,7 M € | -55.6% | 6,0 M € | -51.1% | 12,3 M € | +424.2% | 2,4 M € | -45.7% | 4,3 M € | -57.4% | 10,2 M € | +228.6% | 3,1 M € | +146.3% | 1,3 M € | +289.2% | 323,9 k € | -68.5% | 1,0 M € | -36.6% | 1,6 M € | +210.1% | 522,3 k € | -48.3% | 1,0 M € | +254.9% | 284,5 k € | |
| Debts | 125,2 M € | -26.6% | 170,7 M € | +20.7% | 141,4 M € | +33.4% | 106,0 M € | -7.2% | 114,3 M € | +28.4% | 89,0 M € | +31.2% | 67,9 M € | +213.2% | 21,7 M € | -0.0% | 21,7 M € | -34.2% | 33,0 M € | +123.5% | 14,7 M € | +2.8% | 14,3 M € | -25.3% | 19,2 M € | -15.8% | 22,8 M € | +31.6% | 17,3 M € | +6.0% | 16,3 M € | +22.7% | 13,3 M € | |
| Staff | 246,9 | 254,5 | 258,9 | 265,6 | 265,1 | 272 | 267,1 | 259,9 | 252,2 | 254,6 | 245,7 | 246,1 | 247,9 | 246,1 | 236,6 | 244,2 | 243,4 | |||||||||||||||||
Public limited company · Anzegem · incorporated on 01/03/1985 · 246,9 ETP
Public limited company profitable and well capitalised. Cash position rising (+46.0%).
Solid counterparty for a standard engagement.
Abriso-Jiffy is a Public limited company incorporated in 1985. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Anzegem. It employs on average 246,9 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette